About: ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally. The company offers SOZO Digital Health Platform which transforms fluid status and tissue composition into insights with a single scan; L-Dex Analysis for Lymphedema, designed for early lymphedema detection; BodyComp Analysis; Segmental BodyComp Analysis; and HF-Dex Analysis for Heart Failure. It also provides Lymphedema Prevention Program; and BodyComp Analysis for survivorship health. The company specializes in cancer survivorship, heart health management, medical weight management, wellness, and research. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California.
Sector: Healthcare
Industry: Medical Devices
Latest price: A$0.01 (-16.67%)
IPD ASX Impedimed Ltd
Impedimed Ltd share price
IPD price activity
Último preço
$ 0,010
Variação (24h)
-0,00 AUD (-16,67%)
Volume
6.40M
Volume (média 4 sem.)
-
Abertura
$ 0,01
Variação do dia
$ 0,01 - $ 0,01
Fechamento anterior
$ 0,01
Último negócio
07 Oct, 4:47 am GMT+0
Atrasado
07 Oct, 4:47 am GMT+0
IPD price performance
Atrasado
07 Oct, 4:47 am GMT+0
quote.marketSignals